Services
Genetix Pharmaceuticals
Genetix Pharmaceuticals is committed to advancing the field of gene therapy, providing cutting-edge solutions for the treatment of chronic human diseases and cancers. Our services center around the development and commercialization of effective gene therapies, utilizing our proprietary technology platforms for the stable transfer and expression of therapeutic genes in target cells.
Key services include:
- Gene Therapy Development: Leveraging our next-generation lentiviral gene transfer technology, we develop both in-vivo and ex-vivo therapies targeting genetic blood disorders and severe chronic diseases, such as macular degeneration and neurodegenerative conditions.
- Lentiviral Gene Therapy: Our innovative, extensively engineered lentiviral vectors enable stable transduction of target cells, even non-dividing human cells, providing a powerful platform for safe and effective gene delivery.
- Functional Genomics: Through our advanced functional genomics research, we aim to generate a wide array of proprietary therapeutic genes, with a focus on hematologic malignancies like leukemias and lymphomas.
- Cardiovascular Therapy: We are also pioneering gene-based approaches for promoting angiogenesis in cardiovascular diseases, with our novel therapies currently undergoing pre-clinical testing for coronary artery disease treatment.
By integrating state-of-the-art technology and comprehensive research, Genetix Pharmaceuticals is at the forefront of providing innovative gene therapies to treat some of the most challenging diseases affecting human health.